WallStreetZenWallStreetZen

NASDAQ: APDN
Applied Dna Sciences Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Applied Dna Sciences revenue was $3.74M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $1.2M, up 47.2% from last quarter. For the last reported fiscal year 2024 ending Sep 30, 2024, APDN annual revenue was $3.4M, with -74.3% growth year-over-year.

APDN past revenue growth

How has APDN's revenue growth performed historically?

Company
-58.46%
Industry
4.11%
Market
20.2%
APDN's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
APDN's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
APDN's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

APDN revenue history

Current Revenue
$3.7M
Current Earnings
-$23.6M
Current Profit Margin
-631.3%

Be the first to know when APDN announces revenue.

APDN Revenue History By Year

APDN Yearly RevenueAPDN RevenueAPDN ChangeAPDN Revenue Growth
2024-09-30$3.43M-$9.94M-74.33%
2023-09-30$13.37M-$4.80M-26.43%
2022-09-30$18.17M$9.14M+101.25%
2021-09-30$9.03M$7.10M+367.40%
2020-09-30$1.93M-$3.46M-64.16%
2019-09-30$5.39M$1.49M+38.06%
2018-09-30$3.90M-$847.92k-17.85%
2017-09-30$4.75M$564.83k+13.49%
2016-09-30$4.19M-$4.82M-53.53%
2015-09-30$9.01M$6.29M+231.05%
2014-09-30$2.72M$685.00k+33.64%
2013-09-30$2.04M$181.53k+9.79%
2012-09-30$1.85M$885.85k+91.43%
2011-09-30$968.85k$449.00k+86.37%
2010-09-30$519.84k$224.68k+76.12%
2009-09-30$295.16k-$577.85k-66.19%
2008-09-30$873.01k$751.09k+616.05%
2007-09-30$121.92kN/AN/A

1 of 2

Applied Dna Sciences Revenue FAQ

What was APDN's revenue last quarter?

On Invalid Date, Applied Dna Sciences (NASDAQ: APDN) reported Q4 2024 revenue of $1.20 million up 34.28% year over year. In the same quarter last year, Applied Dna Sciences's revenue was $891.16 thousand.

What was Applied Dna Sciences's revenue in 2024?

Applied Dna Sciences's annual revenue for the twelve months ending Sep 30, 2024 was $3.43 million, a 74.33% decrease year over year.

How much does Applied Dna Sciences make in a day?

Based on Applied Dna Sciences annual revenue for the past five years, APDN makes an average of $25,165.36 per day.

What was Applied Dna Sciences's annual revenue growth in the past year?

As of Q2 2025, Applied Dna Sciences's revenue has grown -58.46% year over year. This is 62.57 percentage points lower than the US Diagnostics & Research industry revenue growth rate of 4.11%. Applied Dna Sciences's revenue in the past year totaled $3.74 million.

How much does Applied Dna Sciences make in a year?

Applied Dna Sciences's revenue by year for the past five years is:
  • Applied Dna Sciences's revenue for the twelve months ending Sep 30, 2024 was $3.43 million, a 74.33% decrease year over year.
  • Applied Dna Sciences's annual revenue for Sep 30, 2023 was $13.37 million, a 26.43% decrease from 2022.
  • Applied Dna Sciences's annual revenue for 2022 was $18.17 million, a 101.25% increase from 2021.
  • Applied Dna Sciences's annual revenue for 2021 was $9.03 million, a 367.4% increase from 2020.
  • Applied Dna Sciences's annual revenue for 2020 was $1.93 million, a 64.16% decrease from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.